Clinical trial

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

NCT02078882

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention abatacept Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-09-01

PhasePHASE4

Conditions

Primary Biliary Cirrhosisverified · MONDO: primary biliary cholangitis

Interventions

abataceptBIOLOGICAL

Sponsors & collaborators

Christopher Bowlus, MDlead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

SacramentoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02078882 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.